SCHEMBL45537

SCHEMBL45537

O=C(CCCCCNC(=O)c1ccccc1C(=O)O)O[O-].[Na+]

nearest known ligand 0.55

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 known ✓ P09917 1/20 0.46
ALDH1A1 P00352 1/20 0.48
HTT P42858 3/20 0.48
TSHR P16473 1/20 0.48
KMT2A Q03164 1/20 0.47
APEX1 P27695 1/20 0.47
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
NAAA Q02083 1/20 0.45
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL721515 0.86 ALDH1A1 (0.53) ALDH1A1HTTTSHRKMT2AAPEX1
SCHEMBL309080 0.86 ALDH1A1 (0.53) ALDH1A1HTTTSHRKMT2AAPEX1
SCHEMBL19077949 0.83 MAPK1 (0.63) ALDH1A1HTTTSHRKMT2AAPEX1
SCHEMBL14088971 0.83 MAPK1 (0.63) ALDH1A1HTTTSHRKMT2AAPEX1
SCHEMBL9134694 0.83 MAPK1 (0.63) ALDH1A1HTTTSHRKMT2AAPEX1
SCHEMBL8655629 0.80 HTT (0.53) HTTTSHRKMT2AAPEX1LMNA
SCHEMBL27891076 0.80 HTT (0.56) HTTTSHRKMT2AAPEX1LMNA
SCHEMBL29696485 0.78 HTT (0.57) ALDH1A1HTTTSHRKMT2AAPEX1
SCHEMBL28809399 0.78 HTT (0.57) ALDH1A1HTTTSHRKMT2AAPEX1
SCHEMBL23610316 0.77 HTT (0.75) ALDH1A1HTTTSHRLMNANAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138222-B2 Whitening agents for cellulosic substrates MILLIKEN & COMPANY (US) 2012-03-20 US disclosed
WO-2011146602-A2 OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME MILLIKEN & COMPANY (US) 2011-11-24 WO disclosed
WO-2011146604-A2 OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME MILLIKEN & COMPANY (US) 2011-11-24 WO disclosed
US-20110283466-A1 OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME MILLIKEN & COMPANY 2011-11-24 US disclosed
US-20110287999-A1 OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME MILLIKEN & COMPANY 2011-11-24 US disclosed
US-8022100-B2 Whitening agents for cellulosic substrates MILLIKEN & CO. (US) 2011-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110283466-A1 OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME DBN1, DKC1, DDB1 ALOX5 3721/4885ALDH1A1 514/4885HTT 393/4885
US-20110287999-A1 OPTICAL BRIGHTENERS AND COMPOSITIONS COMPRISING THE SAME DBN1, AOC1, RARB ALOX5 2501/4885ALDH1A1 546/4885HTT 1351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.